Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Dr. Stelios Papadopoulos,PhDDirector1,187,71313.71%2013-01-30
Mr. Paul SohmerN/A327,9003.79%2014-10-16
Stephen P. HallN/A190,2002.2%2014-10-16
Dr. Aram Adourian, PhDVP, Scientific Affairs185,8362.15%2014-10-16
Dr. Noubar B. Afeyan, PhDDirector, 10% Owner175,7182.03%2014-12-03
Mr. Stephane BancelExecutive Chairman123,1671.42%2012-11-15
Dr. Pieter Muntendam, M.D.EVP, Chief Medical Officer78,4830.91%2012-06-07
Mr. Brian S. PosnerDirector20,0000.23%2012-11-19
Dr. Eric BouvierPresident, CEO10,0000.12%2012-05-23

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
AFEYAN NOUBARDirector, 10% Owner2015-07-27Sell3021,332,712$2.270.7-19.3843,930 (Direct)
58,232 (Held by AGTC Advisors Fund, L.P.)
786,970 (Held by Applied Genomic Technology Capital Fund, L.P.)
2,508 (Held by Atlast LP)
441,072 (Held by Flagship Ventures Fund 2007, L.P.)
AFEYAN NOUBARDirector, 10% Owner2015-07-27Sell4,9801,328,234$2.2711.3-19.3843,930 (Direct)
786,970 (Held by Applied Genomic Technology Capital Fund, L.P.)
53,754 (Held by AGTC Advisors Fund, L.P.)
2,508 (Held by Atlast LP)
441,072 (Held by Flagship Ventures Fund 2007, L.P.)
KANIA EDWIN M JR10% Owner2014-12-11Sell634,3904,915,402$0.32203471.88
0 (Held by OneLiberty Advisors Fund IV, L.P.)
0 (Held by OneLiberty Fund IV, L.P.)
215,013 (Held by AGTC Advisors Fund, L.P.)
2,851,447 (Held by Applied Genomic Technology Capital Fund, L.P.)
1,764,286 (Held by Flagship Ventures Fund 2007, L.P.)
4,232 (Held by OneLiberty Advisors Fund 2000 L.P.)
80,424 (Held by OneLiberty Ventures 2000 L.P.)
AFEYAN NOUBARDirector, 10% Owner2014-12-03Sell2607,917,106$0.460.1297.83
0 (Held by NewcoGen-Long Reign Holding LLC)
2,434,800 (Held by NewcoGen Group LLC)
651,560 (Held by NewcoGen Equity Investors LLC)
215,013 (Held by AGTC Advisors Fund, L.P.)
2,851,447 (Held by Applied Genomic Technology Capital Fund, L.P.)
1,764,286 (Held by Flagship Ventures Fund 2007, L.P.)
AFEYAN NOUBARDirector, 10% Owner2014-12-03Sell2578,009,400$0.460.1297.83
0 (Held by ST NewcoGen LLC)
2,434,800 (Held by NewcoGen Group LLC)
651,560 (Held by NewcoGen Equity Investors LLC)
92,294 (Held by NewcoGen-Long Reign Holding LLC)
215,013 (Held by AGTC Advisors Fund, L.P.)
2,851,447 (Held by Applied Genomic Technology Capital Fund, L.P.)
1,764,286 (Held by Flagship Ventures Fund 2007, L.P.)
AFEYAN NOUBARDirector, 10% Owner2014-12-03Sell1,8485,016,493$0.460.9297.83175,718 (Direct)
0 (Held by NewcoGen Group LLC)
10,029 (Held by Atlast LP)
215,013 (Held by AGTC Advisors Fund, L.P.)
2,851,447 (Held by Applied Genomic Technology Capital Fund, L.P.)
1,764,286 (Held by Flagship Ventures Fund 2007, L.P.)
AFEYAN NOUBARDirector, 10% Owner2014-12-03Sell2,4637,265,546$0.461.1297.83
0 (Held by NewcoGen Equity Investors LLC)
2,434,800 (Held by NewcoGen Group LLC)
215,013 (Held by AGTC Advisors Fund, L.P.)
2,851,447 (Held by Applied Genomic Technology Capital Fund, L.P.)
1,764,286 (Held by Flagship Ventures Fund 2007, L.P.)
PAPADOPOULOS STELIOSDirector2013-01-30Buy250,0001,187,713$2500-8.51,187,713 (Direct)
AFEYAN NOUBARDirector, 10% Owner2013-01-30Buy2,000,0008,186,182$24000-8.5
2,434,800 (By NewcoGen Group LLC)
651,560 (By NewcoGen Equity Investors LLC)
215,013 (By AGTC Advisors Fund, L.P.)
2,851,447 (By Applied Genomic Technology Capital Fund, L.P.)
1,764,286 (By Flagship Ventures Fund 2007, L.P.)
92,294 (By NewcoGen-Long Reign Holding LLC)
92,126 (By ST NewcoGen LLC)
4,232 (By OneLiberty Advisors Fund 2000 L.P.)
80,424 (By OneLiberty Ventures 2000 L.P.)
Posner Brian SDirector2012-11-19Buy10,00020,000$1.1711.756.4120,000 (Direct)
Bancel StephaneExecutive Chairman2012-11-15Buy100,000123,167$1.2612645.24123,167 (Direct)
AFEYAN NOUBARDirector, 10% Owner2012-08-20Sell826,186,182$5.830.5-68.61
0 (By NewcoGen-Elan LLC)
526,560 (By NewcoGen Equity Investors LLC)
92,294 (By NewcoGen-Long Reign Holding LLC)
92,126 (By ST NewcoGen LLC)
140,013 (By AGTC Advisors Fund, L.P.)
2,351,447 (By Applied Genomic Technology Capital Fund, L.P.)
2,184,800 (By NewcoGen Group LLC)
4,232 (By OneLiberty Advisors Fund 2000 L.P.)
80,424 (By OneLiberty Ventures 2000 L.P.)
714,286 (By Flagship Ventures Fund 2007, L.P.)
Muntendam PieterEVP, Chief Medical Officer2012-06-08Sell33,98678,483$5.48186.2-66.6178,483 (Direct)
Bouvier EricPresident, CEO
(Click for the stocks that their CEOs have bought)
2012-05-23Buy10,00010,000$3.9539.5-53.6710,000 (Direct)
Posner Brian SDirector2012-05-22Buy10,00010,000$4.0440.4-54.710,000 (Direct)
AFEYAN NOUBARDirector, 10% Owner2012-05-21Sell1416,462,782$3.950.6-53.67
0 (By NewcoGen-PE LLC)
526,560 (By NewcoGen Equity Investors LLC)
276,600 (By NewcoGen-Elan LLC)
92,294 (By NewcoGen-Long Reign Holding LLC)
92,126 (By ST NewcoGen LLC)
140,013 (By AGTC Advisors Fund, L.P.)
2,351,447 (By Applied Genomic Technology Capital Fund, L.P.)
2,184,800 (By NewcoGen Group LLC)
4,232 (By OneLiberty Advisors Fund 2000 L.P.)
80,424 (By OneLiberty Ventures 2000 L.P.)
714,286 (By Flagship Ventures Fund 2007, L.P.)
Bancel StephaneExecutive Chairman2012-05-17Buy5,00821,786$3.8419.2-52.3421,786 (Direct)
Bancel StephaneExecutive Chairman2012-05-17Buy5,00821,786$3.8419.2-52.3421,786 (Direct)
van der Meer Pieter10% Owner2012-04-17Sell200,0001,635,432$6.61320-72.27
1,635,432 (By Gilde Europe Food & Agribusiness Fund B.V.)
PAPADOPOULOS STELIOSDirector2011-11-29Sell1,078937,713$4.014.3-54.36937,713 (Direct)
Muntendam PieterPresident, CEO2011-09-01Sell1412,469$6.290.1-70.9112,469 (Direct)
van der Meer PieterDirector, 10% Owner2011-02-09Buy142,8570$71000-73.86Link
AGTC Partners, L.P.10% Owner2011-02-09Buy285,7140$72000-73.86Link
AFEYAN NOUBARDirector, 10% Owner2011-02-09Buy1,142,8570$78000-73.86Link
PAPADOPOULOS STELIOSDirector2011-02-09Buy75,0000$7525-73.86Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK